| Ausstehende Aktien | 9,348,201 shares |
| Insider-Aktien | 10.181.989 shares |
| Insider gesamt | 37 |
Insider-Stimmungswert
Der Insider-Stimmungswert ermittelt die Unternehmen, die von Unternehmensinsidern gekauft werden.
Es ist das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Insiderakkumulation identifiziert. Das Scoring-Modell verwendet eine Kombination aus der Nettozahl der Insiderkäufe der letzten 90 Tage, der Gesamtzahl der gekauften Aktien als Prozentsatz des Streubesitzes und der Gesamtzahl der von Insidern gehaltenen Aktien. Die Zahl reicht von 0 bis 100, wobei höhere Zahlen ein höheres Maß an Insiderkäufen anzeigen als bei anderen Unternehmen und 50 den Durchschnitt darstellt.
Aktualisierungshäufigkeit: Täglich
Führungskräfte-Stimmungswert
Der Führungskräfte-Stimmungswert findet Unternehmen, die von Führungskräften des Unternehmens gekauft werden.
Per Definition sind Führungskräfte des Unternehmens Insider, aber im Gegensatz zu anderen Insidern (10%ige Aktionäre und Vorstandsmitglieder) arbeiten Führungskräfte täglich für das Unternehmen und verwenden beim Handel ihr eigenes Geld. (10%ige Aktionäre und Vorstandsmitglieder sind oft Fondsmanager, die das Geld anderer Leute verwalten.) Daher sind Insider-Geschäfte, die von Führungskräften getätigt werden, viel bedeutender und sollten entsprechend behandelt werden.
Wie der Insider-Stimmungswert ist auch der Führungskräfte-Stimmungswert das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Führungskräftekonzentration identifiziert.
Aktualisierungshäufigkeit: Täglich
Wichtige Insider-Kennzahlen
Diese Karte zeigt, wie das Unternehmen bei verschiedenen Insider-Kennzahlen abschneidet. Der Perzentil-Rang zeigt, wie dieses Unternehmen im Vergleich zu anderen Unternehmen auf den US-Märkten abschneidet. Höhere Ränge deuten auf eine bessere Situation hin.
Es ist beispielsweise allgemein anerkannt, dass Insiderkäufe ein positiver Indikator sind, so dass Unternehmen mit mehr Insiderkäufen besser abschneiden würden als Unternehmen mit weniger Insiderkäufen (oder sogar Insiderverkäufen).
Prozent des Streubesitzes von Insidern gekauft (Rang)
10643 out of 10791
Prozent des von Insidern gekauften Streubesitzes ist die Gesamtzahl der von Insidern gekauften Aktien abzüglich der Gesamtzahl der von Insidern in den letzten 90 Tagen verkauften Aktien, geteilt durch den gesamten Streubesitz und multipliziert mit 100.
Diagramm zum Insiderhandel
Adicet Bio, Inc. Insider-Trades sind in der folgenden Grafik dargestellt. Insider sind leitende Angestellte, Direktoren oder bedeutende Investoren in einem Unternehmen. Im Allgemeinen ist es für Insider illegal, auf der Grundlage von wesentlichen, nicht-öffentlichen Informationen mit Aktien ihrer Unternehmen zu handeln. Das bedeutet nicht, dass es für sie illegal ist, irgendwelche Geschäfte in ihren eigenen Unternehmen zu tätigen. Sie müssen jedoch alle Geschäfte der SEC über ein Formular 4 melden.
Kennzahlen zu Insiderlisten und Rentabilität
Diese Tabelle zeigt die Liste der bekannten Insider und wird automatisch aus den bei der SEC eingereichten Unterlagen erstellt. Zusätzlich zu den Namen, dem letzten Titel und der Bezeichnung als Direktor, leitender Angestellter oder 10%-iger Anteilseigner geben wir die zuletzt veröffentlichten Bestände an. Zusätzlich stellen wir, wenn möglich, die historische Handelsperformance für den Insider zur Verfügung. Die historische Handelsperformance ist ein gewichteter Durchschnitt der Performance tatsächlicher offener Kauftransaktionen, die von dem Insider getätigt wurden. Weitere Informationen zur Berechnung dieses Wertes finden Sie in diesem YouTube-Webinar.
See our leaderboard of most profitable insider traders.
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|---|---|---|
| Stewart Abbot | 80.000 | ||
| Blake Aftab Chief Scientific Officer - [O] | 2.981 | 2.981 | |
|
Erez Chimovits
Director, 10% Owner -
[D]
|
396.657 | 60.146 | |
| Jeffrey Chodakewitz Director - [D] | 17.700 | 1.106 | |
| Steve Dubin Director - [D] | 22.700 | 1.419 | |
| Fonteyne Paul R. | 14.414 | ||
|
Carl L Gordon
Director, 10% Owner -
[D]
|
11.458.940 | 716.184 | |
| Francesco Galimi SVP & Chief Medical Officer - [O] | 101.801 | 6.363 | |
| Michael Grissinger | 14.414 | ||
| Brian Nicholas Harvey Chief Financial Officer - [O] | 5.145 | 5.145 | |
| Don Healey Chief Technology Officer - [O] | 3.452 | 3.452 | |
| Aya Jakobovits Director - [D] | 862.562 | 53.910 |
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|---|---|---|
| Michael Kauffman Director - [D] | 5.900 | 369 | |
| Lloyd Klickstein Director - [D] | 108.566 | 6.785 | |
| Carrie Krehlik | 40.000 | ||
| John J Mccabe Vice President, Finance - [O] | 12.867 | 12.867 | |
| Joan Mannick Chief Medical Officer - [O] | 1.404.585 | 1.404.585 | |
| Meredith Manning | 26.000 | ||
|
Orbimed Advisors Llc
10% Owner -
|
0 | 0 | |
| Advisors Israel II Ltd OrbiMed Director - [D] | 242.285 | 0 | |
|
OrbiMed Capital GP V LLC
Director, 10% Owner -
[D]
|
242.285 | 0 | |
|
OrbiMed Capital GP VI LLC
Director, 10% Owner -
[D]
|
242.285 | 0 | |
|
OrbiMed Genesis GP LLC
Director, 10% Owner -
[D]
|
242.285 | 0 | |
| OrbiMed Israel BioFund GP Limited Partnership Director - [D] | 242.285 | 0 |
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|---|---|---|
| OrbiMed Israel GP II, L.P. Director - [D] | 242.285 | 0 | |
| OrbiMed Israel GP Ltd. Director - [D] | 242.285 | 0 | |
| Katie Peng Director - [D] | 11.800 | 738 | |
|
PureTech Health LLC
10% Owner -
|
2.119.696 | 2.119.696 | |
|
Ra Capital Management, Llc
10% Owner -
|
932.624 | 932.624 | |
|
Jonathan Silverstein
Director, 10% Owner -
[D]
|
4.830.387 | 4.830.387 | |
| Bastiano Sanna Director - [D] | 5.900 | 369 | |
| Yair Chaim Schindel Director - [D] | 1.104.460 | 69.029 | |
| Chen Schor President & CEO, Director - [D] [O] | 12.875 | 12.875 | |
| Andrew Sinclair Director - [D] | 17.700 | 1.106 | |
| David Adam Steinberg | 14.414 | ||
| Lynne Marie Sullivan | 14.414 | ||
| Daphne Zohar | 0 |
Report errors via our new Insider Auditing Tool
Erfolgsbilanz der Insiderkäufe - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in ACET / Adicet Bio, Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Erfolgsbilanz von Insiderverkäufen - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in ACET / Adicet Bio, Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Transaktionshistorie
Klicken Sie auf das Link-Symbol, um den vollständigen Transaktionsverlauf anzuzeigen. Transaktionen, die im Rahmen eines automatischen Handelsplans 10b5-1 gemeldet werden, sind in der Spalte 10b-5 mit einem X gekennzeichnet.
| Datei Datum |
Handel Datum |
Form | Insider | Ticker | Wertpapier-Titel | Code | Direkt | Ausführung Preis |
Einheit Preis |
Eimheiten Verändert |
Wert Geändert (1K) |
Verbleibende Optionen |
Verbleibende Aktien |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-29 | 2026-04-27 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | ACET | Common Stock | I | -250.000 | 932.624 | ||||||
| 2026-04-13 | 2026-02-20 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | ACET | Common Stock | I | 7,2700 | 74.751 | 543 | 1.182.624 | ||||
| 2026-04-13 | 2026-02-19 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | ACET | Common Stock | I | 7,2100 | 74.268 | 535 | 1.107.873 | ||||
| 2026-04-13 | 2026-02-18 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | ACET | Common Stock | I | 7,0400 | 74.577 | 525 | 1.033.605 | ||||
| 2026-04-13 | 3 | RA CAPITAL MANAGEMENT, LLC See footnotes | ACET | Common Stock | I | 959.028 | ||||||||
| 2026-04-09 | 2026-04-08 | 4 | ORBIMED ADVISORS LLC See footnotes | ACET | Common Stock | I | 6,5200 | -40.416 | -264 | 0 | ||||
| 2026-04-09 | 2026-04-08 | 4 | ORBIMED ADVISORS LLC See footnotes | ACET | Common Stock | I | 6,2900 | -32.523 | -205 | 0 | ||||
| 2026-04-09 | 2026-04-07 | 4 | ORBIMED ADVISORS LLC See footnotes | ACET | Common Stock | I | 6,3800 | -2.400 | -15 | 32.523 | ||||
| 2026-04-09 | 2026-04-07 | 4 | ORBIMED ADVISORS LLC See footnotes | ACET | Common Stock | I | 6,5300 | -29.319 | -191 | 34.923 | ||||
| 2026-01-27 | 2026-01-24 | 4 | Aftab Blake | ACET | Common Stock | D | 8,4400 | -535 | -5 | 2.981 | ||||
| 2026-01-27 | 2026-01-24 | 4 | Healey Don | ACET | Common Stock | D | 8,4400 | -535 | -5 | 3.452 | ||||
| 2026-01-27 | 2026-01-24 | 4 | Harvey Brian Nicholas | ACET | Common Stock | D | 8,4400 | -546 | -5 | 5.145 | ||||
| 2026-01-27 | 2026-01-24 | 4 | Schor Chen | ACET | Common Stock | D | 8,4400 | -1.755 | -15 | 6.820 | ||||
| 2025-10-10 | 2025-10-08 | 4 | ORBIMED ADVISORS LLC See footnotes | ACET | Common Stock | I | 1,0000 | 3.500.000 | 3.500 | 4.490.254 | ||||
| 2025-10-10 | 2025-10-08 | 4 | ORBIMED ADVISORS LLC See footnotes | ACET | Common Stock | I | 1,0000 | 1.500.000 | 1.500 | 9.026.359 | ||||
| 2025-06-13 | 2025-06-11 | 4 | Klickstein Lloyd | ACET | Common Stock | D | 5.900 | 108.566 | ||||||
| 2025-06-13 | 2025-06-11 | 4 | Chodakewitz Jeffrey | ACET | Common Stock | D | 5.900 | 17.700 | ||||||
| 2025-06-13 | 2025-06-11 | 4 | DUBIN STEVE | ACET | Common Stock | D | 5.900 | 22.700 | ||||||
| 2025-06-13 | 2025-06-11 | 4 | Peng Katie | ACET | Common Stock | D | 5.900 | 11.800 | ||||||
| 2025-06-13 | 2025-06-11 | 4 | Sinclair Andrew | ACET | Common Stock | D | 5.900 | 17.700 | ||||||
| 2025-01-28 | 2025-01-24 | 4 | Schor Chen | ACET | Common Stock | D | 0,9218 | -28.101 | -26 | 137.201 | ||||
| 2025-01-28 | 2025-01-24 | 4 | Healey Don | ACET | Common Stock | D | 0,9218 | -8.560 | -8 | 63.769 | ||||
| 2025-01-28 | 2025-01-24 | 4 | Aftab Blake | ACET | Common Stock | D | 0,9218 | -6.270 | -6 | 56.241 | ||||
| 2025-01-28 | 2025-01-24 | 4 | Harvey Brian Nicholas | ACET | Common Stock | D | 0,9218 | -8.752 | -8 | 91.048 | ||||
| 2024-08-20 | 3 | Klickstein Lloyd | ACET | Common Stock | D | 102.666 | ||||||||
| 2024-06-07 | 2024-06-05 | 4 | GORDON CARL L | ACET | Common Stock | D | 5.900 | 11.800 | ||||||
| 2024-06-07 | 2024-06-05 | 4 | Chodakewitz Jeffrey | ACET | Common Stock | D | 5.900 | 11.800 | ||||||
| 2024-06-07 | 2024-06-05 | 4 | DUBIN STEVE | ACET | Common Stock | D | 5.900 | 16.800 | ||||||
| 2024-06-07 | 2024-06-05 | 4 | Jakobovits Aya | ACET | Common Stock | D | 5.900 | 11.800 | ||||||
| 2024-06-07 | 2024-06-05 | 4 | Kauffman Michael | ACET | Common Stock | D | 1,4300 | -5.900 | -8 | 5.900 | ||||
| 2024-06-07 | 2024-06-05 | 4 | Kauffman Michael | ACET | Common Stock | D | 5.900 | 11.800 | ||||||
| 2024-06-07 | 2024-06-05 | 4 | Peng Katie | ACET | Common Stock | D | 5.900 | 5.900 | ||||||
| 2024-06-07 | 2024-06-05 | 4 | Sinclair Andrew | ACET | Common Stock | D | 5.900 | 11.800 | ||||||
| 2024-01-26 | 2024-01-25 | 4 | ORBIMED ADVISORS LLC See footnotes | ACET | Common Stock | I | 2,4000 | 1.041.700 | 2.500 | 1.255.985 | ||||
| 2024-01-26 | 2024-01-25 | 4 | ORBIMED ADVISORS LLC See footnotes | ACET | Common Stock | I | 2,4000 | 242.200 | 581 | 990.254 | ||||
| 2024-01-26 | 2024-01-25 | 4 | ORBIMED ADVISORS LLC See footnotes | ACET | Common Stock | I | 2,4000 | 1.841.100 | 4.419 | 7.526.359 | ||||
| 2024-01-26 | 2024-01-25 | 4 | GORDON CARL L See footnotes | ACET | Common Stock | I | 2,4000 | 1.041.700 | 2.500 | 1.255.985 | ||||
| 2024-01-26 | 2024-01-25 | 4 | GORDON CARL L See footnotes | ACET | Common Stock | I | 2,4000 | 242.200 | 581 | 990.254 | ||||
| 2024-01-26 | 2024-01-25 | 4 | GORDON CARL L See footnotes | ACET | Common Stock | I | 2,4000 | 1.841.100 | 4.419 | 7.526.359 | ||||
| 2024-01-26 | 2024-01-24 | 4 | Galimi Francesco | ACET | Common Stock | D | 26.300 | 101.801 | ||||||
| 2024-01-26 | 2024-01-24 | 4 | Galimi Francesco | ACET | Common Stock | D | 2,4000 | -4.957 | -12 | 75.501 | ||||
| 2024-01-26 | 2024-01-24 | 4 | Aftab Blake | ACET | Common Stock | D | 19.700 | 62.511 | ||||||
| 2024-01-26 | 2024-01-24 | 4 | Aftab Blake | ACET | Common Stock | D | 2,4000 | -3.565 | -9 | 42.811 | ||||
| 2024-01-26 | 2024-01-24 | 4 | Healey Don | ACET | Common Stock | D | 19.700 | 72.329 | ||||||
| 2024-01-26 | 2024-01-24 | 4 | Healey Don | ACET | Common Stock | D | 2,4000 | -4.870 | -12 | 52.629 | ||||
| 2024-01-26 | 2024-01-24 | 4 | Harvey Brian Nicholas | ACET | Common Stock | D | 26.300 | 99.800 | ||||||
| 2024-01-26 | 2024-01-24 | 4 | Harvey Brian Nicholas | ACET | Common Stock | D | 2,4000 | -4.320 | -10 | 73.500 | ||||
| 2024-01-26 | 2024-01-24 | 4 | Schor Chen | ACET | Common Stock | D | 70.300 | 208.771 | ||||||
| 2024-01-26 | 2024-01-24 | 4 | Schor Chen | ACET | Common Stock | D | 2,4000 | -15.290 | -37 | 138.471 | ||||
| 2023-10-16 | 2023-10-12 | 4 | Aftab Blake | ACET | Common Stock | D | 1,3500 | -7.933 | -11 | 46.376 | ||||
| 2023-10-03 | 2023-10-02 | 4 | Galimi Francesco | ACET | Common Stock | D | 1,3700 | -8.093 | -11 | 80.458 | ||||
| 2023-10-03 | 2023-10-02 | 4 | Healey Don | ACET | Common Stock | D | 1,3700 | -9.069 | -12 | 57.499 | ||||
| 2023-10-03 | 2023-10-02 | 4 | Harvey Brian Nicholas | ACET | Common Stock | D | 1,3700 | -7.096 | -10 | 77.820 | ||||
| 2023-10-02 | 2023-10-02 | 4 | Schor Chen | ACET | Common Stock | D | 1,3700 | -23.208 | -32 | 153.761 | ||||
| 2023-10-02 | 2023-10-02 | 4 | Schor Chen | ACET | Common Stock | I | 1,3345 | 5.500 | 7 | 43.469 | ||||
| 2023-10-02 | 2023-09-29 | 4 | Schor Chen | ACET | Common Stock | D | 1,3601 | -5.500 | -7 | 176.969 | ||||
| 2023-10-02 | 2023-09-28 | 4 | Schor Chen | ACET | Common Stock | D | 1,4200 | 5.500 | 8 | 182.469 | ||||
| 2023-10-02 | 2023-09-28 | 4 | Schor Chen | ACET | Common Stock | I | 1,4200 | -5.500 | -8 | 37.969 | ||||
| 2023-06-30 | 2023-06-30 | 4 | DUBIN STEVE | ACET | Common Stock | D | 2,3999 | 5.000 | 12 | 10.900 | ||||
| 2023-06-29 | 2023-06-27 | 4 | GORDON CARL L See footnotes | ACET | Common Stock | I | 2,0900 | 58.000 | 121 | 748.054 | ||||
| 2023-06-29 | 2023-06-27 | 4 | GORDON CARL L See footnotes | ACET | Common Stock | I | 2,0900 | 442.000 | 924 | 5.685.259 | ||||
| 2023-06-29 | 2023-06-27 | 4 | GORDON CARL L See footnotes | ACET | Common Stock | I | 2,0900 | 250.000 | 522 | 646.657 | ||||
| 2023-06-29 | 2023-06-27 | 4 | GORDON CARL L See footnotes | ACET | Common Stock | I | 2,0900 | 125.000 | 261 | 1.027.885 | ||||
| 2023-06-29 | 2023-06-27 | 4 | ORBIMED ADVISORS LLC See footnotes | ACET | Common Stock | I | 2,0900 | 58.000 | 121 | 748.054 | ||||
| 2023-06-29 | 2023-06-27 | 4 | ORBIMED ADVISORS LLC See footnotes | ACET | Common Stock | I | 2,0900 | 442.000 | 924 | 5.685.259 | ||||
| 2023-06-29 | 2023-06-27 | 4 | ORBIMED ADVISORS LLC See footnotes | ACET | Common Stock | I | 2,0900 | 250.000 | 522 | 646.657 | ||||
| 2023-06-29 | 2023-06-27 | 4 | ORBIMED ADVISORS LLC See footnotes | ACET | Common Stock | I | 2,0900 | 125.000 | 261 | 1.027.885 | ||||
| 2023-06-02 | 2023-06-01 | 4 | Chodakewitz Jeffrey | ACET | Common Stock | D | 5.900 | 5.900 | ||||||
| 2023-06-02 | 2023-06-01 | 4 | Jakobovits Aya | ACET | Common Stock | D | 5.900 | 5.900 | ||||||
| 2023-06-02 | 2023-06-01 | 4 | Kauffman Michael | ACET | Common Stock | D | 5.900 | 5.900 | ||||||
| 2023-06-02 | 2023-06-01 | 4 | Sanna Bastiano | ACET | Common Stock | D | 5.900 | 5.900 | ||||||
| 2023-06-02 | 2023-06-01 | 4 | DUBIN STEVE | ACET | Common Stock | D | 5.900 | 5.900 | ||||||
| 2023-06-02 | 2023-06-01 | 4 | GORDON CARL L | ACET | Common Stock | D | 5.900 | 5.900 | ||||||
| 2023-06-02 | 2023-06-01 | 4 | Sinclair Andrew | ACET | Common Stock | D | 5.900 | 5.900 | ||||||
| 2023-02-17 | 2023-02-15 | 4 | Healey Don | ACET | Common Stock | D | 7,5726 | -4.533 | -34 | 66.568 | ||||
| 2023-02-14 | 2022-11-14 | 5 | Schor Chen | ACET | Common Stock | D | 9.955 | 48.000 | ||||||
| 2023-02-14 | 2022-11-14 | 5 | Schor Chen | ACET | Common Stock | I | -9.955 | 43.469 | ||||||
| 2023-02-14 | 2022-10-17 | 5 | Schor Chen | ACET | Common Stock | I | 26.712 | 53.424 | ||||||
| 2023-02-14 | 2022-10-17 | 5 | Schor Chen | ACET | Common Stock | D | -26.712 | 38.045 | ||||||
| 2023-02-14 | 2022-09-28 | 5 | Schor Chen | ACET | Common Stock | I | 26.712 | 26.712 | ||||||
| 2023-02-14 | 2022-09-28 | 5 | Schor Chen | ACET | Common Stock | D | -26.712 | 64.757 | ||||||
| 2023-02-14 | 2022-09-27 | 5 | Schor Chen | ACET | Common Stock | D | 26.712 | 91.469 | ||||||
| 2023-02-14 | 2022-09-27 | 5 | Schor Chen | ACET | Common Stock | I | -26.712 | 0 | ||||||
| 2023-02-14 | 2022-09-13 | 5 | Schor Chen | ACET | Common Stock | I | 26.712 | 26.712 | ||||||
| 2023-02-14 | 2022-09-13 | 5 | Schor Chen | ACET | Common Stock | D | -26.712 | 64.757 | ||||||
| 2023-02-14 | 2023-02-10 | 4 | Healey Don | ACET | Common Stock | D | 7,9752 | -10.467 | -83 | 71.101 | ||||
| 2023-01-26 | 2023-01-24 | 4 | Schor Chen | ACET | Common Stock | D | 85.500 | 176.969 | ||||||
| 2023-01-26 | 2023-01-24 | 4 | Aftab Blake | ACET | Common Stock | D | 26.100 | 54.309 | ||||||
| 2023-01-26 | 2023-01-24 | 4 | Galimi Francesco | ACET | Common Stock | D | 26.100 | 88.551 | ||||||
| 2023-01-26 | 2023-01-24 | 4 | Healey Don | ACET | Common Stock | D | 26.100 | 81.568 | ||||||
| 2023-01-26 | 2023-01-24 | 4 | Harvey Brian Nicholas | ACET | Common Stock | D | 26.100 | 84.916 | ||||||
| 2022-11-15 | 2022-11-10 | 4 | Schor Chen | ACET | Common Stock | I | 20,0640 | -30.000 | -602 | 53.424 | ||||
| 2022-11-15 | 2022-11-10 | 4 | Schor Chen | ACET | Common Stock | D | 21,0268 | -9.955 | -209 | 91.469 | ||||
| 2022-11-15 | 2022-11-10 | 4 | Aftab Blake | ACET | Common Stock | D | 21,0000 | -6.967 | -146 | 28.209 | ||||
| 2022-11-09 | 2022-11-07 | 4 | Schor Chen | ACET | Common Stock | I | 19,0496 | -30.000 | -571 | 83.424 | ||||
| 2022-11-04 | 2022-11-03 | 4 | Schor Chen | ACET | Common Stock | I | 18,0437 | -24.813 | -448 | 113.424 | ||||
| 2022-11-04 | 2022-11-02 | 4 | Schor Chen | ACET | Common Stock | I | 18,0000 | -500 | -9 | 138.237 | ||||
| 2022-10-21 | 2022-10-19 | 4 | Aftab Blake | ACET | Common Stock | D | 16,2700 | -8.067 | -131 | 35.176 | ||||
| 2022-10-14 | 2022-10-13 | 4 | Aftab Blake | ACET | Common Stock | D | 15,9200 | -7.933 | -126 | 43.243 | ||||
| 2022-10-14 | 2022-10-12 | 4 | Aftab Blake | ACET | Common Stock | D | 15,4000 | -1.646 | -25 | 51.176 | ||||
| 2022-10-14 | 2022-10-12 | 4 | Aftab Blake | ACET | Common Stock | D | 7,3800 | 3.388 | 25 | 52.822 | ||||
| 2022-10-04 | 2022-10-04 | 4 | Schor Chen | ACET | Common Stock | D | 14,2200 | -21.288 | -303 | 101.424 | ||||
| 2022-10-04 | 2022-10-04 | 4 | Healey Don | ACET | Common Stock | D | 14,2200 | -7.933 | -113 | 55.468 | ||||
| 2022-10-04 | 2022-10-04 | 4 | Harvey Brian Nicholas | ACET | Common Stock | D | 14,2200 | -7.096 | -101 | 58.816 | ||||
| 2022-10-04 | 2022-10-04 | 4 | Galimi Francesco | ACET | Common Stock | D | 14,2200 | -7.933 | -113 | 62.451 | ||||
| 2022-09-16 | 2022-09-14 | 4 | Schor Chen | ACET | Common Stock | I | 18,0000 | -952 | -17 | 138.737 | ||||
| 2022-09-13 | 2022-09-13 | 4 | Schor Chen | ACET | Common Stock | I | 18,0105 | -3.371 | -61 | 139.689 | ||||
| 2022-09-13 | 2022-09-12 | 4 | Schor Chen | ACET | Common Stock | I | 18,0000 | -200 | -4 | 143.060 | ||||
| 2022-09-13 | 2022-09-12 | 4 | Schor Chen | ACET | Common Stock | I | 16,7694 | -66.747 | -1.119 | 0 | ||||
| 2022-09-13 | 2022-09-09 | 4 | Schor Chen | ACET | Common Stock | I | 16,5062 | -8.094 | -134 | 66.747 | ||||
| 2022-08-08 | 2022-08-04 | 4 | Schor Chen | ACET | Common Stock | D | 18,2500 | -21.288 | -389 | 122.712 | ||||
| 2022-08-08 | 2022-08-04 | 4 | Schor Chen | ACET | Common Stock | D | 48.000 | 144.000 | ||||||
| 2022-08-08 | 2022-07-06 | 4 | Schor Chen | ACET | Common Stock | I | 53.424 | 143.260 | ||||||
| 2022-08-08 | 2022-07-06 | 4 | Schor Chen | ACET | Common Stock | D | -53.424 | 96.000 | ||||||
| 2022-08-08 | 2022-08-04 | 4 | Galimi Francesco | ACET | Common Stock | D | 18,2500 | -5.533 | -101 | 70.384 | ||||
| 2022-08-08 | 2022-08-04 | 4 | Galimi Francesco | ACET | Common Stock | D | 16.000 | 75.917 | ||||||
| 2022-08-08 | 2022-08-04 | 4 | Aftab Blake | ACET | Common Stock | D | 18,2500 | -5.533 | -101 | 49.434 | ||||
| 2022-08-08 | 2022-08-04 | 4 | Aftab Blake | ACET | Common Stock | D | 16.000 | 54.967 | ||||||
| 2022-08-08 | 2022-08-04 | 4 | Harvey Brian Nicholas | ACET | Common Stock | D | 18,2500 | -4.696 | -86 | 65.912 | ||||
| 2022-08-08 | 2022-08-04 | 4 | Harvey Brian Nicholas | ACET | Common Stock | D | 16.000 | 70.608 | ||||||
| 2022-08-08 | 2022-08-04 | 4 | Healey Don | ACET | Common Stock | D | 18,2500 | -5.533 | -101 | 63.401 | ||||
| 2022-08-08 | 2022-08-04 | 4 | Healey Don | ACET | Common Stock | D | 16.000 | 68.934 | ||||||
| 2022-08-05 | 2022-08-03 | 4 | Aftab Blake | ACET | Common Stock | D | 18,0000 | -6.968 | -125 | 38.967 | ||||
| 2022-08-03 | 2022-08-01 | 4 | Aftab Blake | ACET | Common Stock | D | 16,6400 | -6.968 | -116 | 45.935 | ||||
| 2022-07-07 | 2022-07-05 | 4 | Aftab Blake | ACET | Common Stock | D | 14,5000 | -1.363 | -20 | 52.903 | ||||
| 2022-05-12 | 2022-05-10 | 4 | Aftab Blake | ACET | Stock Option (Right to Buy) | D | 12,18 | 60.000 | 60.000 | |||||
| 2022-04-05 | 2022-04-04 | 4 | Galimi Francesco | ACET | Employee Stock Option (Right to Buy) | D | 16,82 | -1.775 | 26.625 | |||||
| 2022-04-05 | 2022-04-04 | 4 | Galimi Francesco | ACET | Employee Stock Option (Right to Buy) | D | 5,97 | -168 | 113.652 | |||||
| 2022-04-05 | 2022-04-04 | 4 | Galimi Francesco | ACET | Employee Stock Option (Right to Buy) | D | 13,27 | -6.036 | 73.964 | |||||
| 2022-04-05 | 2022-04-04 | 4 | Galimi Francesco | ACET | Common Stock | D | 21,0000 | -1.775 | -37 | 59.917 | ||||
| 2022-04-05 | 2022-04-04 | 4 | Galimi Francesco | ACET | Common Stock | D | 16,8200 | 1.775 | 30 | 61.692 | ||||
| 2022-04-05 | 2022-04-04 | 4 | Galimi Francesco | ACET | Common Stock | D | 21,0000 | -168 | -4 | 59.917 | ||||
| 2022-04-05 | 2022-04-04 | 4 | Galimi Francesco | ACET | Common Stock | D | 5,9700 | 168 | 1 | 60.085 | ||||
| 2022-04-05 | 2022-04-04 | 4 | Galimi Francesco | ACET | Common Stock | D | 21,0000 | -6.036 | -127 | 59.917 | ||||
| 2022-04-05 | 2022-04-04 | 4 | Galimi Francesco | ACET | Common Stock | D | 13,2700 | 6.036 | 80 | 65.953 | ||||
| 2022-04-05 | 2022-04-01 | 4 | Galimi Francesco | ACET | Employee Stock Option (Right to Buy) | D | 5,97 | -7.621 | 113.820 | |||||
| 2022-04-05 | 2022-04-01 | 4 | Galimi Francesco | ACET | Common Stock | D | 21,0000 | -7.621 | -160 | 59.917 | ||||
| 2022-04-05 | 2022-04-01 | 4 | Galimi Francesco | ACET | Common Stock | D | 5,9700 | 7.621 | 45 | 67.538 | ||||
| 2022-03-11 | 2022-03-09 | 4 | Jakobovits Aya | ACET | Common Stock | I | 14,0000 | -2.000 | -28 | 356.345 | ||||
| 2022-03-11 | 2022-03-09 | 4 | Jakobovits Aya | ACET | Common Stock | I | 14,0000 | -2.000 | -28 | 356.345 | ||||
| 2022-02-17 | 2022-02-16 | 4 | Jakobovits Aya | ACET | Common Stock | I | 14,8319 | -2.000 | -30 | 358.345 | ||||
| 2022-02-17 | 2022-02-16 | 4 | Jakobovits Aya | ACET | Common Stock | I | 14,8319 | -2.000 | -30 | 358.343 | ||||
| 2022-02-16 | 2022-02-14 | 4 | Healey Don | ACET | Common Stock | D | 14,2700 | -5.533 | -79 | 52.934 | ||||
| 2022-02-16 | 2022-02-14 | 4 | Healey Don | ACET | Common Stock | D | 16.000 | 58.467 | ||||||
| 2022-02-16 | 2022-02-14 | 4 | Aftab Blake | ACET | Common Stock | D | 14,2700 | -5.533 | -79 | 52.903 | ||||
| 2022-02-16 | 2022-02-14 | 4 | Aftab Blake | ACET | Common Stock | D | 16.000 | 58.436 | ||||||
| 2022-02-16 | 2022-02-14 | 4 | Galimi Francesco | ACET | Common Stock | D | 14,2700 | -5.533 | -79 | 59.917 | ||||
| 2022-02-16 | 2022-02-14 | 4 | Galimi Francesco | ACET | Common Stock | D | 16.000 | 65.450 | ||||||
| 2022-02-16 | 2022-02-14 | 4 | Harvey Brian Nicholas | ACET | Common Stock | D | 14,2700 | -4.696 | -67 | 54.608 | ||||
| 2022-02-16 | 2022-02-14 | 4 | Harvey Brian Nicholas | ACET | Common Stock | D | 16.000 | 59.304 | ||||||
| 2022-02-16 | 2022-02-14 | 4 | Schor Chen | ACET | Common Stock | D | 14,2700 | -21.288 | -304 | 149.424 | ||||
| 2022-02-16 | 2022-02-14 | 4 | Schor Chen | ACET | Common Stock | D | 48.000 | 170.712 | ||||||
| 2022-02-14 | 2022-02-09 | 4 | Jakobovits Aya | ACET | Common Stock | I | 14,0303 | -4.000 | -56 | 360.345 | ||||
| 2022-02-14 | 2022-02-09 | 4 | Jakobovits Aya | ACET | Common Stock | I | 14,0294 | -4.000 | -56 | 360.343 | ||||
| 2022-02-14 | 2022-01-05 | 4 | Jakobovits Aya | ACET | Common Stock | I | 16,8995 | -2.000 | -34 | 364.345 | ||||
| 2022-02-14 | 2022-01-05 | 4 | Jakobovits Aya | ACET | Common Stock | I | 16,9320 | -2.000 | -34 | 364.343 | ||||
| 2022-02-14 | 2022-01-03 | 4 | Jakobovits Aya | ACET | Common Stock | I | 18,0218 | -6.000 | -108 | 366.345 | ||||
| 2022-02-14 | 2022-01-03 | 4 | Jakobovits Aya | ACET | Common Stock | I | 18,0208 | -6.000 | -108 | 366.343 | ||||
| 2022-02-14 | 2021-12-23 | 5 | Jakobovits Aya | ACET | Common Stock | I | 39.792 | 372.345 | ||||||
| 2022-02-14 | 2021-12-23 | 5 | Jakobovits Aya | ACET | Common Stock | I | 39.791 | 372.343 | ||||||
| 2022-02-14 | 2021-12-23 | 5 | Jakobovits Aya | ACET | Common Stock | I | 29.905 | 138.076 | ||||||
| 2022-02-14 | 2021-12-23 | 5 | Jakobovits Aya | ACET | Common Stock | I | -109.488 | 0 | ||||||
| 2022-02-14 | 2021-12-22 | 5 | Jakobovits Aya | ACET | Common Stock | I | 16,0286 | -7.000 | -112 | 332.553 | ||||
| 2022-02-14 | 2021-12-22 | 5 | Jakobovits Aya | ACET | Common Stock | I | 16,0162 | -7.000 | -112 | 332.552 | ||||
| 2022-02-01 | 2022-01-28 | 4 | Galimi Francesco | ACET | Common Stock | D | 11,6900 | -5.533 | -65 | 49.450 | ||||
| 2022-02-01 | 2022-01-28 | 4 | Galimi Francesco | ACET | Common Stock | D | 16.000 | 54.983 | ||||||
| 2022-02-01 | 2022-01-28 | 4 | Healey Don | ACET | Common Stock | D | 11,6900 | -5.533 | -65 | 42.467 | ||||
| 2022-02-01 | 2022-01-28 | 4 | Healey Don | ACET | Common Stock | D | 16.000 | 48.000 | ||||||
| 2022-02-01 | 2022-01-28 | 4 | Aftab Blake | ACET | Common Stock | D | 11,6900 | -5.564 | -65 | 42.436 | ||||
| 2022-02-01 | 2022-01-28 | 4 | Aftab Blake | ACET | Common Stock | D | 16.000 | 48.000 | ||||||
| 2022-02-01 | 2022-01-28 | 4 | Harvey Brian Nicholas | ACET | Common Stock | D | 11,6900 | -4.696 | -55 | 43.304 | ||||
| 2022-02-01 | 2022-01-28 | 4 | Harvey Brian Nicholas | ACET | Common Stock | D | 16.000 | 48.000 | ||||||
| 2022-02-01 | 2022-01-28 | 4 | Schor Chen | ACET | Common Stock | D | 11,6900 | -21.288 | -249 | 122.712 | ||||
| 2022-02-01 | 2022-01-28 | 4 | Schor Chen | ACET | Common Stock | D | 48.000 | 144.000 | ||||||
| 2022-01-11 | 2022-01-07 | 4 | Harvey Brian Nicholas | ACET | Stock Option (Right to Buy | D | 15,52 | 125.000 | 125.000 | |||||
| 2022-01-11 | 2022-01-07 | 4 | Aftab Blake | ACET | Stock Option (Right to Buy) | D | 15,52 | 125.000 | 125.000 | |||||
| 2022-01-11 | 2022-01-07 | 4 | Galimi Francesco | ACET | Stock Option (Right to Buy) | D | 15,52 | 125.000 | 125.000 | |||||
| 2022-01-11 | 2022-01-07 | 4 | Healey Don | ACET | Stock Option (Right to Buy) | D | 15,52 | 125.000 | 125.000 | |||||
| 2022-01-11 | 2022-01-07 | 4 | Schor Chen | ACET | Stock Option (Right to Buy) | D | 15,52 | 295.000 | 295.000 | |||||
| 2021-12-14 | 2021-12-10 | 4 | GORDON CARL L See Footnotes | ACET | Common Stock | I | 14,0000 | 214.285 | 3.000 | 242.285 | ||||
| 2021-12-14 | 2021-12-10 | 4 | ORBIMED ADVISORS LLC See Footnotes | ACET | Common Stock | I | 14,0000 | 214.285 | 3.000 | 242.285 | ||||
| 2021-12-13 | 2021-12-08 | 4/A | Sinclair Andrew | ACET | Common Stock | I | 14,0000 | 500.000 | 7.000 | 2.115.385 | ||||
| 2021-12-10 | 2021-12-08 | 4 | Sinclair Andrew | ACET | Common Stock | I | 14,0000 | 500.000 | 7.000 | 2.140.721 | ||||
| 2021-11-18 | 2021-11-17 | 4 | Kauffman Michael | ACET | Stock Option (right to Buy) | D | 9,39 | 37.000 | 37.000 | |||||
| 2021-10-13 | 2021-10-12 | 4 | Aftab Blake | ACET | Stock Option (right to Buy) | D | 7,38 | 60.000 | 60.000 | |||||
| 2021-10-13 | 2021-10-12 | 4 | Aftab Blake | ACET | Common Stock | D | 80.000 | 80.000 | ||||||
| 2021-10-05 | 2021-10-01 | 4 | Schor Chen | ACET | Common Stock | D | 240.000 | 240.000 | ||||||
| 2021-10-05 | 2021-10-01 | 4 | Galimi Francesco | ACET | Common Stock | D | 80.000 | 86.983 | ||||||
| 2021-10-05 | 2021-10-01 | 4 | Healey Don | ACET | Common Stock | D | 80.000 | 80.000 | ||||||
| 2021-10-05 | 2021-10-01 | 4 | Harvey Brian Nicholas | ACET | Common Stock | D | 80.000 | 80.000 | ||||||
| 2021-06-21 | 2021-06-16 | 4 | Schor Chen | ACET | Common Stock | I | 10,5334 | -8.982 | -95 | 89.836 | ||||
| 2021-06-21 | 2021-06-16 | 4 | Schor Chen | ACET | Common Stock | I | 10,5334 | -7.484 | -79 | 74.841 | ||||
| 2021-06-17 | 2021-06-15 | 4 | Jakobovits Aya | ACET | Common Stock | I | 11,1565 | -1.923 | -21 | 215.883 | ||||
| 2021-06-17 | 2021-06-15 | 4 | Jakobovits Aya | ACET | Common Stock | I | 11,1565 | -1.924 | -21 | 215.883 | ||||
| 2021-06-14 | 2021-06-11 | 4 | ABBOT STEWART | ACET | Non-Qualified Option (right to buy) | D | 11,75 | 5.000 | 5.000 | |||||
| 2021-06-08 | 2021-06-04 | 4 | Galimi Francesco | ACET | Employee Stock Option (Right to Buy) | D | 5,97 | -6.983 | 121.441 | |||||
| 2021-06-08 | 2021-06-04 | 4 | Galimi Francesco | ACET | Common Stock | D | 5,9700 | 6.983 | 42 | 6.983 | ||||
| 2021-06-07 | 2021-06-03 | 4 | Schor Chen | ACET | Common Stock | I | 12,0551 | -8.982 | -108 | 98.818 | ||||
| 2021-06-07 | 2021-06-03 | 4 | Schor Chen | ACET | Common Stock | I | 12,0551 | -7.484 | -90 | 82.325 | ||||
| 2021-05-21 | 2021-05-19 | 4 | Schor Chen | ACET | Common Stock | I | 13,7277 | -733 | -10 | 107.800 | ||||
| 2021-05-21 | 2021-05-19 | 4 | Schor Chen | ACET | Common Stock | I | 13,4232 | -8.249 | -111 | 108.533 | ||||
| 2021-05-21 | 2021-05-19 | 4 | Schor Chen | ACET | Common Stock | I | 13,7277 | -612 | -8 | 89.809 | ||||
| 2021-05-21 | 2021-05-19 | 4 | Schor Chen | ACET | Common Stock | I | 13,4232 | -6.872 | -92 | 90.421 | ||||
| 2021-05-20 | 2021-05-20 | 4 | Jakobovits Aya | ACET | Common Stock | I | 14,2280 | -900 | -13 | 217.806 | ||||
| 2021-05-20 | 2021-05-20 | 4 | Jakobovits Aya | ACET | Common Stock | I | 14,2291 | -892 | -13 | 217.807 | ||||
| 2021-05-20 | 2021-05-18 | 4 | Jakobovits Aya | ACET | Common Stock | I | 14,0558 | -3.100 | -44 | 218.706 | ||||
| 2021-05-20 | 2021-05-18 | 4 | Jakobovits Aya | ACET | Common Stock | I | 14,0527 | -3.108 | -44 | 218.699 | ||||
| 2021-05-14 | 2021-05-12 | 4 | Jakobovits Aya | ACET | Common Stock | I | 13,2409 | -5.000 | -66 | 221.806 | ||||
| 2021-05-14 | 2021-05-12 | 4 | Jakobovits Aya | ACET | Common Stock | I | 13,2256 | -5.000 | -66 | 221.807 | ||||
| 2021-05-07 | 2021-05-05 | 4 | Schor Chen | ACET | Common Stock | I | 14,7006 | -3.670 | -54 | 116.782 | ||||
| 2021-05-07 | 2021-05-05 | 4 | Schor Chen | ACET | Common Stock | I | 13,8957 | -5.312 | -74 | 120.452 | ||||
| 2021-05-07 | 2021-05-05 | 4 | Schor Chen | ACET | Common Stock | I | 14,7006 | -3.058 | -45 | 97.293 | ||||
| 2021-05-07 | 2021-05-05 | 4 | Schor Chen | ACET | Common Stock | I | 13,8957 | -4.426 | -62 | 100.351 | ||||
| 2021-05-04 | 2021-04-30 | 4 | Sinclair Andrew | ACET | Stock Option (Right to Buy) | D | 15,93 | 8.172 | 8.172 | |||||
| 2021-05-04 | 2021-04-30 | 4 | Sinclair Andrew | ACET | Stock Option (Right to Buy) | D | 15,93 | 18.500 | 18.500 | |||||
| 2021-05-04 | 2021-04-30 | 4 | Jakobovits Aya | ACET | Stock Option (Right to Buy) | D | 15,93 | 18.500 | 18.500 | |||||
| 2021-05-04 | 2021-04-30 | 4 | Sanna Bastiano | ACET | Stock Option (Right to Buy) | D | 15,93 | 1.172 | 1.172 | |||||
| 2021-05-04 | 2021-04-30 | 4 | Sanna Bastiano | ACET | Stock Option (Right to Buy) | D | 15,93 | 18.500 | 18.500 | |||||
| 2021-05-04 | 2021-04-30 | 4 | GORDON CARL L | ACET | Stock Option (Right to Buy) | D | 15,93 | 18.500 | 18.500 | |||||
| 2021-05-04 | 2021-04-30 | 4 | DUBIN STEVE | ACET | Stock Option (Right to Buy) | D | 15,93 | 18.500 | 18.500 | |||||
| 2021-05-04 | 2021-04-30 | 4 | Chodakewitz Jeffrey | ACET | Stock Option (Right to Buy) | D | 15,93 | 18.500 | 18.500 | |||||
| 2021-04-22 | 2021-04-20 | 4 | Schor Chen | ACET | Common Stock | I | 12,0051 | -7.484 | -90 | 104.777 | ||||
| 2021-04-22 | 2021-04-20 | 4 | Schor Chen | ACET | Common Stock | I | 12,0051 | -8.982 | -108 | 125.764 | ||||
| 2021-04-08 | 2021-04-06 | 4 | Schor Chen | ACET | Common Stock | I | 13,0390 | -7.484 | -98 | 112.261 | ||||
| 2021-04-08 | 2021-04-06 | 4 | Schor Chen | ACET | Common Stock | I | 13,0390 | -8.982 | -117 | 134.746 | ||||
| 2021-04-01 | 2021-03-30 | 4 | Schor Chen | ACET | Common Stock | I | 13,2200 | -4.500 | -59 | 119.745 | ||||
| 2021-04-01 | 2021-03-30 | 4 | Schor Chen | ACET | Common Stock | I | 13,2200 | -5.400 | -71 | 143.728 | ||||
| 2021-04-01 | 2021-03-30 | 4 | Schor Chen | ACET | Common Stock | I | 12,3000 | -2.984 | -37 | 124.245 | ||||
| 2021-04-01 | 2021-03-30 | 4 | Schor Chen | ACET | Common Stock | I | 12,3000 | -3.582 | -44 | 149.128 | ||||
| 2021-04-01 | 2021-03-16 | 4/A | Schor Chen | ACET | Common Stock | I | 15,6600 | -2.089 | -33 | 127.229 | ||||
| 2021-04-01 | 2021-03-16 | 4/A | Schor Chen | ACET | Common Stock | I | 15,0700 | -2.508 | -38 | 152.710 | ||||
| 2021-04-01 | 2021-03-16 | 4/A | Schor Chen | ACET | Common Stock | I | 15,6600 | -5.395 | -84 | 129.318 | ||||
| 2021-04-01 | 2021-03-16 | 4/A | Schor Chen | ACET | Common Stock | I | 15,0700 | -6.474 | -98 | 155.218 | ||||
| 2021-04-01 | 2021-01-25 | 4/A | Schor Chen | ACET | Common Stock | I | -27.014 | 0 | ||||||
| 2021-04-01 | 2021-01-25 | 4/A | Schor Chen | ACET | Common Stock | I | -19.286 | 0 | ||||||
| 2021-04-01 | 2021-01-22 | 4/A | Schor Chen | ACET | Common Stock | I | -23.570 | 0 | ||||||
| 2021-04-01 | 2021-01-22 | 4/A | Schor Chen | ACET | Common Stock | I | -22.985 | 0 | ||||||
| 2021-04-01 | 2021-01-22 | 4/A | Schor Chen | ACET | Common Stock | D | -26.070 | 0 | ||||||
| 2021-04-01 | 2020-10-23 | 4/A | Schor Chen | ACET | Common Stock | D | -8.649 | 26.070 | ||||||
| 2021-03-18 | 2021-03-16 | 4 | Schor Chen | ACET | Common Stock | I | 15,6600 | -2.089 | -33 | 127.229 | ||||
| 2021-03-18 | 2021-03-16 | 4 | Schor Chen | ACET | Common Stock | I | 15,0700 | -2.508 | -38 | 152.710 | ||||
| 2021-03-18 | 2021-03-16 | 4 | Schor Chen | ACET | Common Stock | I | 15,6600 | -5.395 | -84 | 129.318 | ||||
| 2021-03-18 | 2021-03-16 | 4 | Schor Chen | ACET | Common Stock | I | 15,0700 | -6.474 | -98 | 155.218 | ||||
| 2021-03-18 | 2020-10-23 | 4 | Klickstein Lloyd | ACET | Common Stock | D | -4.957 | 11.931 | ||||||
| 2021-03-18 | 2019-12-06 | 4 | Klickstein Lloyd | ACET | Common Stock | D | -16.888 | 16.888 | ||||||
| 2021-03-16 | 2021-03-02 | 4/A | Sinclair Andrew | ACET | Stock Option (Right to Buy) | D | 15,75 | 28.828 | 28.828 | |||||
| 2021-03-16 | 3/A | Sinclair Andrew | ACET | Common Stock | I | 1.615.385 | ||||||||
| 2021-03-04 | 3 | Sinclair Andrew | ACET | Common Stock | I | 1.640.721 | ||||||||
| 2021-03-04 | 2021-03-02 | 4 | Sinclair Andrew | ACET | Stock Option (Right to Buy) | D | 15,75 | 28.828 | 28.828 | |||||
| 2021-02-18 | 2021-02-12 | 4 | Chimovits Erez See Footnotes | ACET | Common Stock | I | 13,0000 | 104.050 | 1.353 | 396.657 | ||||
| 2021-02-18 | 2021-02-12 | 4 | Chimovits Erez See Footnotes | ACET | Common Stock | I | 13,0000 | 420.299 | 5.464 | 5.243.259 | ||||
| 2021-02-18 | 2021-02-12 | 4 | GORDON CARL L See Footnotes | ACET | Common Stock | I | 13,0000 | 104.050 | 1.353 | 396.657 | ||||
| 2021-02-18 | 2021-02-12 | 4 | GORDON CARL L See Footnotes | ACET | Common Stock | I | 13,0000 | 420.299 | 5.464 | 5.243.259 | ||||
| 2021-02-18 | 2021-02-12 | 4 | ORBIMED ADVISORS LLC See Footnotes | ACET | Common Stock | I | 13,0000 | 104.050 | 1.353 | 396.657 | ||||
| 2021-02-18 | 2021-02-12 | 4 | ORBIMED ADVISORS LLC See Footnotes | ACET | Common Stock | I | 13,0000 | 420.299 | 5.464 | 5.243.259 | ||||
| 2021-02-17 | 2021-02-12 | 4 | ABBOT STEWART | ACET | Stock Option (Right to Buy) | D | 16,82 | 106.900 | 106.900 | |||||
| 2021-02-17 | 2021-02-12 | 4 | Klickstein Lloyd | ACET | Stock Option (Right to Buy) | D | 16,82 | 41.100 | 41.100 | |||||
| 2021-02-17 | 2021-02-12 | 4 | Harvey Brian Nicholas | ACET | Stock Option (Right to Buy) | D | 16,82 | 28.200 | 28.200 | |||||
| 2021-02-17 | 2021-02-12 | 4 | Healey Don | ACET | Stock Option (Right to Buy) | D | 16,82 | 30.400 | 30.400 | |||||
| 2021-02-17 | 2021-02-12 | 4 | Krehlik Carrie | ACET | Stock Option (Right to Buy) | D | 16,82 | 11.200 | 11.200 | |||||
| 2021-02-17 | 2021-02-12 | 4 | Schor Chen | ACET | Stock Option (Right to Buy) | D | 16,82 | 421.600 | 421.600 | |||||
| 2021-02-17 | 2021-02-12 | 4 | Galimi Francesco | ACET | Stock Option (Right to Buy) | D | 16,82 | 28.400 | 28.400 | |||||
| 2021-01-15 | 2021-01-13 | 4 | Harvey Brian Nicholas | ACET | Stock Option (Right to Buy) | D | 13,27 | 90.000 | 90.000 | |||||
| 2021-01-15 | 2021-01-13 | 4 | ABBOT STEWART | ACET | Stock Option (Right to Buy) | D | 13,27 | 80.000 | 80.000 | |||||
| 2021-01-15 | 2021-01-13 | 4 | Schor Chen | ACET | Stock Option (Right to Buy) | D | 13,27 | 240.000 | 240.000 | |||||
| 2021-01-15 | 2021-01-13 | 4 | Galimi Francesco | ACET | Stock Option (Right to Buy) | D | 13,27 | 80.000 | 80.000 | |||||
| 2021-01-15 | 2021-01-13 | 4 | Krehlik Carrie | ACET | Stock Option (Right to Buy) | D | 13,27 | 40.000 | 40.000 | |||||
| 2021-01-15 | 2021-01-13 | 4 | Healey Don | ACET | Stock Option (Right to Buy) | D | 13,27 | 70.000 | 70.000 | |||||
| 2021-01-15 | 2021-01-13 | 4 | Klickstein Lloyd | ACET | Stock Option (Right to Buy) | D | 13,27 | 80.000 | 80.000 | |||||
| 2020-12-03 | 2020-12-01 | 4 | Sanna Bastiano | ACET | Stock Option (Right to Buy) | D | 12,00 | 28.828 | 28.828 | |||||
| 2020-10-29 | 2020-10-27 | 4 | Healey Don | ACET | Non-Qualified Option (right to buy) | D | 12,23 | 166.605 | 166.605 | |||||
| 2020-10-27 | 2020-10-23 | 4 | Schor Chen | ACET | Common Stock | D | -8.649 | 72.499 | ||||||
| 2020-09-17 | 2020-09-17 | 4 | Schindel Yair Chaim | ACET | Non-Qualified Stock Option (right to buy) | D | 16,11 | 30.000 | 30.000 | |||||
| 2020-09-17 | 2020-09-15 | 4 | Schindel Yair Chaim By aMoon 2 Fund Limited Partnership | ACET | Common Stock | I | 1.104.460 | 1.104.460 | ||||||
| 2020-09-17 | 2020-09-17 | 4 | Klickstein Lloyd | ACET | Stock Option (Right to Buy) | D | 16,11 | 193.027 | 193.027 | |||||
| 2020-09-17 | 2020-09-17 | 4 | Jakobovits Aya | ACET | Non-Qualified Stock Option (right to buy) | D | 16,11 | 30.000 | 30.000 | |||||
| 2020-09-17 | 2020-09-15 | 4 | Jakobovits Aya By grantor retained irrevocable trust. | ACET | Common Stock | I | 77.500 | 77.500 | ||||||
| 2020-09-17 | 2020-09-15 | 4 | Jakobovits Aya By grantor retained irrevocable trust. | ACET | Common Stock | I | 77.500 | 77.500 | ||||||
| 2020-09-17 | 2020-09-15 | 4 | Jakobovits Aya By grantor retained annuity trust. | ACET | Common Stock | I | 135.799 | 135.799 | ||||||
| 2020-09-17 | 2020-09-15 | 4 | Jakobovits Aya By grantor retained annuity trusts. | ACET | Common Stock | I | 627.812 | 627.812 | ||||||
| 2020-09-17 | 2020-09-17 | 4 | DUBIN STEVE | ACET | Stock Option (Right to Buy) | D | 16,11 | 30.000 | 30.000 | |||||
| 2020-09-17 | 2020-09-17 | 4 | Schor Chen | ACET | Stock Option (Right to Buy) | D | 16,11 | 872.111 | 872.111 | |||||
| 2020-09-17 | 2020-09-17 | 4 | Krehlik Carrie | ACET | Incentive Stock Option (right to buy) | D | 16,11 | 40.391 | 40.391 | |||||
| 2020-09-17 | 2020-09-15 | 4 | Krehlik Carrie | ACET | Employee Stock Option (right to buy) | D | 5,97 | 15.450 | 15.450 | |||||
| 2020-09-17 | 2020-09-15 | 4 | Krehlik Carrie | ACET | Employee Stock Option (right to buy) | D | 2,26 | 18.600 | 18.600 | |||||
| 2020-09-17 | 2020-09-17 | 4 | ABBOT STEWART | ACET | Incentive Stock Option (right to buy) | D | 16,11 | 63.751 | 63.751 | |||||
| 2020-09-17 | 2020-09-15 | 4 | ABBOT STEWART | ACET | Employee Stock Option (right to buy) | D | 5,97 | 57.151 | 57.151 | |||||
| 2020-09-17 | 2020-09-15 | 4 | ABBOT STEWART | ACET | Employee Stock Option (right to buy) | D | 2,26 | 84.791 | 84.791 | |||||
| 2020-09-17 | 2020-09-17 | 4 | Chodakewitz Jeffrey | ACET | Stock Option (Right to Buy) | D | 16,11 | 30.000 | 30.000 | |||||
| 2020-09-17 | 2020-09-17 | 4 | Chimovits Erez | ACET | Stock Option (Right to Buy) | D | 16,11 | 30.000 | 30.000 | |||||
| 2020-09-17 | 2020-09-15 | 4 | Chimovits Erez See Footnotes | ACET | Common Stock | I | 292.607 | 292.607 | ||||||
| 2020-09-17 | 2020-09-15 | 4 | Chimovits Erez See Footnotes | ACET | Common Stock | I | 902.885 | 902.855 | ||||||
| 2020-09-17 | 3 | Chimovits Erez | ACET | No securities are beneficially owned | I | 0 | ||||||||
| 2020-09-17 | 2020-09-17 | 4 | ORBIMED ADVISORS LLC | ACET | Stock Option (Right to Buy) | I | 16,11 | 30.000 | 30.000 | |||||
| 2020-09-17 | 2020-09-17 | 4 | ORBIMED ADVISORS LLC | ACET | Stock Option (Right to Buy) | I | 16,11 | 30.000 | 30.000 | |||||
| 2020-09-17 | 2020-09-15 | 4 | ORBIMED ADVISORS LLC See Footnotes | ACET | Common Stock | I | 292.607 | 292.607 | ||||||
| 2020-09-17 | 2020-09-15 | 4 | ORBIMED ADVISORS LLC See Footnotes | ACET | Common Stock | I | 902.885 | 902.855 | ||||||
| 2020-09-17 | 2020-09-15 | 4 | ORBIMED ADVISORS LLC See Footnotes | ACET | Common Stock | I | 4.822.960 | 4.822.960 | ||||||
| 2020-09-17 | 2020-09-17 | 4 | Galimi Francesco | ACET | Incentive Stock Option (right to buy) | D | 16,11 | 77.269 | 77.269 | |||||
| 2020-09-17 | 2020-09-15 | 4 | Galimi Francesco | ACET | Employee Stock Option (right to buy) | D | 5,97 | 128.424 | 128.424 | |||||
| 2020-09-17 | 2020-09-17 | 4 | GORDON CARL L | ACET | Stock Option (Right to Buy) | D | 16,11 | 30.000 | 30.000 | |||||
| 2020-09-17 | 2020-09-15 | 4 | GORDON CARL L See Footnotes | ACET | Common Stock | I | 292.607 | 292.607 | ||||||
| 2020-09-17 | 2020-09-15 | 4 | GORDON CARL L See Footnotes | ACET | Common Stock | I | 902.885 | 902.855 | ||||||
| 2020-09-17 | 2020-09-15 | 4 | GORDON CARL L See Footnotes | ACET | Common Stock | I | 4.822.960 | 4.822.960 | ||||||
| 2020-09-17 | 3 | OrbiMed Israel BioFund GP Limited Partnership | ACET | No securities are beneficially owned | I | 0 | ||||||||
| 2020-09-17 | 3 | GORDON CARL L See Footnotes | ACET | Common stock | I | 690.055 | ||||||||
| 2020-06-05 | 2020-06-03 | 4 | Chodakewitz Jeffrey | TORC | Stock Option (Right to Buy) | D | 2,23 | 14.414 | 14.414 | |||||
| 2020-06-05 | 2020-06-03 | 4 | Steinberg David Adam | TORC | Stock Option (Right to Buy) | D | 2,23 | 14.414 | 14.414 | |||||
| 2020-06-05 | 2020-06-03 | 4 | Sullivan Lynne Marie | TORC | Stock Option (Right to Buy) | D | 2,23 | 14.414 | 14.414 | |||||
| 2020-06-05 | 2020-06-03 | 4 | SILVERSTEIN JONATHAN | TORC | Stock Option (Right to Buy) | D | 2,23 | 14.414 | 14.414 | |||||
| 2020-06-05 | 2020-06-03 | 4 | FONTEYNE PAUL R. | TORC | Stock Option (Right to Buy) | D | 2,23 | 14.414 | 14.414 | |||||
| 2020-06-05 | 2020-06-03 | 4 | Grissinger Michael | TORC | Stock Option (Right to Buy) | D | 2,23 | 14.414 | 14.414 | |||||
| 2019-12-19 | 2019-12-18 | 4 | PureTech Health LLC | TORC | Common Stock | D | 1,2000 | -6.161.531 | -7.394 | 2.119.696 | ||||
| 2019-12-17 | 2019-12-13 | 4 | PureTech Health LLC | TORC | Common Stock | D | 1,2432 | -205.763 | -256 | 8.281.227 | ||||
| 2019-12-12 | 2019-12-12 | 4 | PureTech Health LLC | TORC | Common Stock | D | 1,2499 | -385.884 | -482 | 8.486.990 | ||||
| 2019-12-12 | 2019-12-11 | 4 | PureTech Health LLC | TORC | Common Stock | D | 1,2500 | -59.921 | -75 | 8.872.874 | ||||
| 2019-12-12 | 2019-12-10 | 4 | PureTech Health LLC | TORC | Common Stock | D | 1,2588 | -336.561 | -424 | 8.932.795 | ||||
| 2019-12-06 | 2019-12-06 | 4 | Schor Chen | TORC | Stock Option (Right to Buy) | D | 1,27 | 258.000 | 258.000 | |||||
| 2019-12-06 | 2019-12-06 | 4 | Schor Chen | TORC | Common Stock | D | 344.000 | 669.000 | ||||||
| 2019-12-06 | 2019-12-06 | 4 | Klickstein Lloyd | TORC | Stock Option (Right to Buy) | D | 1,27 | 88.667 | 88.667 | |||||
| 2019-12-06 | 2019-12-06 | 4 | Klickstein Lloyd | TORC | Common Stock | D | 118.222 | 118.222 | ||||||
| 2019-12-06 | 2019-12-06 | 4 | MCCABE JOHN J | TORC | Stock Option (Right to Buy) | D | 1,27 | 16.400 | 16.400 | |||||
| 2019-12-06 | 2019-12-06 | 4 | MCCABE JOHN J | TORC | Common Stock | D | 12.867 | 12.867 | ||||||
| 2019-12-06 | 2019-12-06 | 4 | Mannick Joan | TORC | Stock Option (Right to Buy) | D | 1,27 | 88.667 | 88.667 | |||||
| 2019-12-06 | 2019-12-06 | 4 | Mannick Joan | TORC | Common Stock | D | 118.222 | 1.404.585 | ||||||
| 2019-11-19 | 2019-11-15 | 4 | PureTech Health LLC | TORC | Common Stock | D | 1,2465 | -531.040 | -662 | 9.269.356 | ||||
| 2019-05-15 | 2019-05-13 | 4 | Klickstein Lloyd | TORC | Stock Option (Right to Buy) | D | 8,08 | 295.000 | 295.000 | |||||
| 2019-05-09 | 2019-05-08 | 4 | Steinberg David Adam | TORC | Stock Option (Right to Buy) | D | 7,99 | 14.414 | 14.414 | |||||
| 2019-05-09 | 2019-05-08 | 4 | FONTEYNE PAUL R. | TORC | Stock Option (Right to Buy) | D | 7,99 | 14.414 | 14.414 | |||||
| 2019-05-09 | 2019-05-08 | 4 | Chodakewitz Jeffrey | TORC | Stock Option (Right to Buy) | D | 7,99 | 14.414 | 14.414 | |||||
| 2019-05-09 | 2019-05-08 | 4 | Grissinger Michael | TORC | Stock Option (Right to Buy) | D | 7,99 | 14.414 | 14.414 | |||||
| 2019-05-09 | 2019-05-08 | 4 | SILVERSTEIN JONATHAN | TORC | Stock Option (Right to Buy) | D | 7,99 | 14.414 | 14.414 | |||||
| 2019-05-09 | 2019-05-08 | 4 | Sullivan Lynne Marie | TORC | Stock Option (Right to Buy) | D | 7,99 | 14.414 | 14.414 | |||||
| 2019-02-28 | 2019-02-27 | 4 | MCCABE JOHN J | TORC | Stock Option (Right to Buy) | D | 8,53 | 24.600 | 24.600 | |||||
| 2019-02-28 | 2019-02-27 | 4 | Manning Meredith | TORC | Stock Option (Right to Buy) | D | 8,53 | 26.000 | 26.000 | |||||
| 2019-02-28 | 2019-02-27 | 4 | Schor Chen | TORC | Stock Option (Right to Buy) | D | 8,53 | 214.000 | 214.000 | |||||
| 2019-02-28 | 2019-02-27 | 4 | Mannick Joan | TORC | Stock Option (Right to Buy) | D | 8,53 | 93.000 | 93.000 | |||||
| 2018-12-17 | 2018-10-26 | 4 | Mannick Joan | TORC | Common Stock | I | 600.000 | 600.000 | ||||||
| 2018-12-17 | 2018-10-26 | 4 | Mannick Joan | TORC | Common Stock | D | -600.000 | 1.286.363 | ||||||
| 2018-12-17 | 2018-11-05 | 4 | Schor Chen | TORC | Common Stock | D | -6.000 | 325.000 | ||||||
| 2018-12-17 | 2018-10-15 | 4 | Schor Chen | TORC | Common Stock | I | -25.000 | 943.000 | ||||||
| 2018-12-17 | 2018-10-15 | 4 | Schor Chen | TORC | Common Stock | D | -25.000 | 943.000 | ||||||
| 2018-12-17 | 2018-10-15 | 4 | Schor Chen | TORC | Common Stock | I | -643.000 | 943.000 | ||||||
| 2018-12-17 | 2018-10-15 | 4 | Schor Chen | TORC | Common Stock | D | -593.363 | 356.000 | ||||||
| 2018-12-17 | 2018-07-06 | 4 | Schor Chen | TORC | Common Stock | D | -943.000 | 949.363 | ||||||
| 2018-11-06 | 2018-11-05 | 4 | Grissinger Michael | TORC | Stock Option (Right to Buy) | D | 11,82 | 28.828 | 28.828 | |||||
| 2018-09-18 | 2018-09-17 | 4 | Manning Meredith | TORC | Stock Option (Right to Buy) | D | 13,94 | 175.000 | 175.000 | |||||
| 2018-08-15 | 2018-08-14 | 4 | Chodakewitz Jeffrey | TORC | Stock Option (Right to Buy) | D | 10,42 | 28.828 | 28.828 | |||||
| 2018-04-17 | 2018-04-16 | 4 | Schor Chen | TORC | Common Stock | D | 8,9533 | 2.000 | 18 | 1.892.363 | ||||
| 2018-04-12 | 2018-04-11 | 4 | Schor Chen | TORC | Common Stock | D | 9,3621 | 2.000 | 19 | 1.890.363 | ||||
| 2018-04-11 | 2018-04-10 | 4 | Schor Chen | TORC | Common Stock | D | 8,4574 | 2.000 | 17 | 1.888.363 | ||||
| 2018-03-14 | 2018-03-13 | 4 | MCCABE JOHN J | TORC | Stock Option (Right to Buy) | D | 15,45 | 4.603 | 4.603 | |||||
| 2018-01-30 | 2018-01-30 | 4 | PureTech Health LLC | TORC | Series A Preferred Stock | D | -7.680.700 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | PureTech Health LLC | TORC | Common Stock | D | 15,0000 | 233.333 | 3.500 | 9.800.396 | ||||
| 2018-01-30 | 2018-01-30 | 4 | PureTech Health LLC | TORC | Common Stock | D | 7.680.700 | 9.567.063 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | ORBIMED ADVISORS LLC See Footnotes | TORC | Series B Preferred Stock | I | -1.871.569 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | ORBIMED ADVISORS LLC See Footnotes | TORC | Series A Preferred Stock | I | -2.425.482 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | ORBIMED ADVISORS LLC See Footnotes | TORC | Common Stock | I | 15,0000 | 533.333 | 8.000 | 4.830.387 | ||||
| 2018-01-30 | 2018-01-30 | 4 | ORBIMED ADVISORS LLC See Footnotes | TORC | Common Stock | I | 1.871.569 | 4.297.054 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | ORBIMED ADVISORS LLC See Footnotes | TORC | Common Stock | I | 2.425.485 | 2.425.485 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | SILVERSTEIN JONATHAN See Footnotes | TORC | Series B Preferred Stock | I | -1.871.569 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | SILVERSTEIN JONATHAN See Footnotes | TORC | Series A Preferred Stock | I | -2.425.482 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | SILVERSTEIN JONATHAN See Footnotes | TORC | Common Stock | I | 15,0000 | 533.333 | 8.000 | 4.830.387 | ||||
| 2018-01-30 | 2018-01-30 | 4 | SILVERSTEIN JONATHAN See Footnotes | TORC | Common Stock | I | 1.871.569 | 4.297.054 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | SILVERSTEIN JONATHAN See Footnotes | TORC | Common Stock | I | 2.425.485 | 2.425.485 | ||||||
| 2018-01-25 | 3 | Mannick Joan | TORC | Common Stock | D | 3.772.726 | ||||||||
| 2018-01-25 | 3 | Mannick Joan | TORC | Common Stock | D | 3.772.726 | ||||||||
| 2018-01-25 | 3 | PureTech Health LLC | TORC | Common Stock | D | 3.772.726 | ||||||||
| 2018-01-25 | 3 | PureTech Health LLC | TORC | Common Stock | D | 3.772.726 | ||||||||
| 2018-01-25 | 3 | Schor Chen | TORC | Common Stock | D | 3.772.726 | ||||||||
| 2018-01-25 | 3 | Schor Chen | TORC | Common Stock | D | 3.772.726 |
P
Offener Markt oder privater Kauf von nicht-derivativen oder derivativen Wertpapieren
S
Freiverkauf oder privater Verkauf von nicht-derivativen oder derivativen Wertpapieren
A
Gewährung, Vergabe oder sonstiger Erwerb von Wertpapieren des Unternehmens (z. B. eine Option)
C
Umwandlung von Derivaten
D
Verkauf oder Rückübertragung von Wertpapieren an das Unternehmen
F
Zahlung des Ausübungspreises oder der Steuerschuld mit einem Teil der vom Unternehmen erhaltenen Wertpapiere
G
Schenkung von Wertpapieren durch oder an den Insider
K
Aktien-Swaps und ähnliche Absicherungstransaktionen
M
Ausübung oder Umwandlung eines vom Unternehmen erhaltenen derivativen Wertpapiers (z. B. einer Option)
V
Eine freiwillig auf Formular 4 gemeldete Transaktion
J
Sonstige (mit einer Fußnote zur Beschreibung der Transaktion)
